Dr Eva Baxter
Senior Research Fellow Platform in Molecular Gynaecological Cancer Research
Frazer Institute
Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
+61 7 334 66049
Researcher biography
Dr Baxter is a Senior Research Platform Fellow at the Queensland Centre for Gynaecological Cancer (QCGC) Research and leads its molecular research program. Her research focuses on biomarker discovery and validation to improve clinical outcomes for women with gynaecological cancers. Dr Baxter leads translational studies embedded within QCGC Research's clinical trials, including the feMMe phase II trial (NCT01686126), which demonstrated that approximately 60% of women with early-stage endometrial cancer can safely avoid hysterectomy through intrauterine progestin therapy. She also leads translational studies for the ongoing ENDO-3 phase III trial (NCT04073706), evaluating the risks and benefits of sentinel node biopsy in early-stage endometrial cancer. Her research bridges molecular science and clinical trials, advancing precision medicine in gynaecological oncology.
Journal Articles
Baxter, Eva, Robledo, Kristy P., Janda, Monika and Obermair, Andreas (2026). Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial. International Journal of Gynecological Cancer 104725, 104725. doi: 10.1016/j.ijgc.2026.104725
Yu, Michael, Baxter, Eva and Obermair, Andreas (2026). Response to: considerations on interpreting temporal trends in a scoping review of endometrial cancer care. International Journal of Gynecological Cancer 104720, 104720. doi: 10.1016/j.ijgc.2026.104720
Yu, Michael, Baxter, Eva and Obermair, Andreas (2026). Changes and trends in endometrial cancer patterns of care: a scoping review of the literature from 2000 to 2024. International Journal of Gynecological Cancer, 36 (4) 104614, 1-11. doi: 10.1016/j.ijgc.2026.104614
Zomerdijk, Nienke, Janda, Monika, Mulcahy, Ella, Baxter, Eva and Roberts, Natasha (2026). Women’s lived experiences of being diagnosed with early-stage endometrial cancer and making treatment decisions: a systematic review and thematic synthesis. International Journal of Gynecological Cancer 104687, 104687. doi: 10.1016/j.ijgc.2026.104687
Baxter, Eva, Nair, Soumyalekshmi, West, Zoe, Salomon, Carlos and Obermair, Andreas (2025). Extracellular vesicles as biomarkers for endometrial cancer – a systematic review. Translational Oncology, 62 102543, 1-10. doi: 10.1016/j.tranon.2025.102543
Baxter, Eva, Robledo, Kristy P., Cummings, Margaret, Alizart, Michelle, Smith, Deborah and Obermair, Andreas (2025). Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial. American Journal of Surgical Pathology, 50 (2), 259-266. doi: 10.1097/pas.0000000000002492
Baxter, Eva, Robledo, Kristy, Gebski, Val, Chen, Chen, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James, Chetty, Naven, Janda, Monika and Obermair, Andreas (2025). LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL. International Journal of Gynecological Cancer, 35 (11) 102239, 102239. doi: 10.1016/j.ijgc.2025.102239
Obermair, Andreas, Gebski, Val, Goh, Jeffrey, Kuchel, Anna, Brand, Alison, Mak, Blossom, McNally, Orla, Baxter, Eva, Jobling, Thomas and Mileshkin, Linda (2025). Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644)). International Journal of Gynecological Cancer, 35 (9) 101961, 1-2. doi: 10.1016/j.ijgc.2025.101961
Obermair, A., Gebski, V., Goh, J., Kuchel, A., Brand, A., Mak, B., McNally, O., Baxter, E., Jobling, T. and Mileshkin, L. (2025). A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer, 35 (4) 101644, 1-9. doi: 10.1016/j.ijgc.2025.101644
Obermair, Andreas, Nicklin, Jim, Gebski, Val, Hayes, Sandra C., Graves, Nicholas, Mileshkin, Linda, Lin, Ming Yin, Beale, Phillip, Baxter, Eva, Robledo, Kristy, Salomon, Carlos, Hanna, George B. and Janda, Monika (2021). A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020. International Journal of Gynecologic Cancer, 31 (12) ijgc-2021-003029, 1595-1601. doi: 10.1136/ijgc-2021-003029
Obermair, Andreas, Baxter, Eva, Brennan, Donal J., McAlpine, Jessica N., Muellerer, Jennifer J., Amant, Frédéric, van Gent, Mignon D. J. M., Coleman, Robert L., Westin, Shannon N., Yates, Melinda S., Krakstad, Camilla and Janda, Monika (2020). Fertility-sparing treatment in early endometrial cancer: current state and future strategies. Obstetrics and Gynecology Science, 63 (4), 417-431. doi: 10.5468/ogs.19169
Baxter, Eva, Brennan, Donal J, McAlpine, Jessica N, Mueller, Jennifer J, Amant, Frédéric, van Gent, Mignon D J M, Huntsman, David G, Coleman, Robert L, Westin, Shannon N, Yates, Melinda S, Krakstad, Camilla, Quinn, Michael A, Janda, Monika and Obermair, Andreas (2020). Improving response to progestin treatment of low-grade endometrial cancer. International Journal of Gynecologic Cancer, 30 (11) ijgc-2020-001309, ijgc-2020. doi: 10.1136/ijgc-2020-001309
Donohoe, Fionán, Wilkinson, Michael, Baxter, Eva and Brennan, Donal J. (2020). Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer. International Journal of Molecular Sciences, 21 (4) 1241, 1-19. doi: 10.3390/ijms21041241
Casciello, Francesco, Al-Ejeh, Fares, Miranda, Mariska, Kelly, Greg, Baxter, Eva, Windloch, Karolina, Gannon, Frank and Lee, Jason S. (2020). G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome. Theranostics, 10 (10), 4515-4529. doi: 10.7150/thno.41453
Baxter, Eva, Windloch, Karolina, Kelly, Greg, Lee, Jason S., Gannon, Frank and Brennan, Donal (2019). Molecular basis of distinct oestrogen responses in endometrial and breast cancer. Endocrine-Related Cancer, 26 (1), 31-46. doi: 10.1530/ERC-17-0563
Jacquelin, Sebastien, Straube, Jasmin, Cooper, Leanne, Vu, Therese, Song, Axia, Bywater, Megan, Baxter, Eva, Heidecker, Matthew, Wackrow, Brad, Porter, Amy, Ling, Victoria, Green, Joanne, Austin, Rebecca, Kazakoff, Stephen, Waddell, Nicola, Hesson, Luke B., Pimanda, John E., Stegelmann, Frank, Bullinger, Lars, Döhner, Konstanze, Rampal, Raajit K., Heckl, Dirk, Hill, Geoffrey R. and Lane, Steven W. (2018). Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation. Blood, 132 (26), blood-2018. doi: 10.1182/blood-2018-04-846220
Obermair, Andreas, Brennan, Donal J., Baxter, Eva, Armes, Jane E., Gebski, Val and Janda, Monika (2016). Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy. Gynecologic Oncology Research and Practice, 3 (1), 1. doi: 10.1186/s40661-016-0023-8
Baxter, Eva, Windloch, Karolina, Gannon, Frank and Lee, Jason S. (2014). Epigenetic regulation in cancer progression. Cell & Bioscience, 4 (1) 45, 45. doi: 10.1186/2045-3701-4-45
Conference Paper
Obermair, Andreas, West, Zoe, Baxter, Eva, Condous, George, Hacker, Neville, Lord, Sally, Mccarthy, Sandie, Janda, Monika, Tuffaha, Haitham, Hayes, Sandi, Disipio, Tracey, Mellon, Anne, Gebski, Val, Mcnally, Orla and Martin, Andrew (2024). EV430/#358 Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis. IGCS 2024 Annual Meeting, Dublin, Ireland, 16-18 October 2024. London, United Kingdom: BMJ Group. doi: 10.1136/ijgc-2024-igcs.551